1. Home
  2. FSBC vs MLYS Comparison

FSBC vs MLYS Comparison

Compare FSBC & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSBC
  • MLYS
  • Stock Information
  • Founded
  • FSBC 2002
  • MLYS 2019
  • Country
  • FSBC United States
  • MLYS United States
  • Employees
  • FSBC N/A
  • MLYS N/A
  • Industry
  • FSBC Banks
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSBC Finance
  • MLYS Health Care
  • Exchange
  • FSBC Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • FSBC 565.6M
  • MLYS 1.0B
  • IPO Year
  • FSBC 2021
  • MLYS 2023
  • Fundamental
  • Price
  • FSBC $29.76
  • MLYS $14.30
  • Analyst Decision
  • FSBC Buy
  • MLYS Strong Buy
  • Analyst Count
  • FSBC 4
  • MLYS 4
  • Target Price
  • FSBC $34.75
  • MLYS $27.00
  • AVG Volume (30 Days)
  • FSBC 58.5K
  • MLYS 871.8K
  • Earning Date
  • FSBC 07-23-2025
  • MLYS 08-12-2025
  • Dividend Yield
  • FSBC 2.69%
  • MLYS N/A
  • EPS Growth
  • FSBC N/A
  • MLYS N/A
  • EPS
  • FSBC 2.27
  • MLYS N/A
  • Revenue
  • FSBC $124,973,000.00
  • MLYS N/A
  • Revenue This Year
  • FSBC $25.86
  • MLYS N/A
  • Revenue Next Year
  • FSBC $15.15
  • MLYS N/A
  • P/E Ratio
  • FSBC $13.11
  • MLYS N/A
  • Revenue Growth
  • FSBC 11.14
  • MLYS N/A
  • 52 Week Low
  • FSBC $22.22
  • MLYS $8.24
  • 52 Week High
  • FSBC $35.13
  • MLYS $18.38
  • Technical
  • Relative Strength Index (RSI)
  • FSBC 67.71
  • MLYS 48.08
  • Support Level
  • FSBC $28.32
  • MLYS $13.22
  • Resistance Level
  • FSBC $30.04
  • MLYS $14.35
  • Average True Range (ATR)
  • FSBC 0.79
  • MLYS 0.76
  • MACD
  • FSBC 0.27
  • MLYS -0.04
  • Stochastic Oscillator
  • FSBC 92.71
  • MLYS 51.92

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: